Transdiagnostic CBT for bedtime procrastination: a pilot randomized controlled trial targeting behavioral, cognitive, and emotional dimensions

针对睡前拖延症的跨诊断认知行为疗法:一项针对行为、认知和情绪维度的试点随机对照试验

阅读:1

Abstract

OBJECTIVES: Bedtime procrastination (BP) is a significant contributor to insufficient sleep. While existing interventions primarily focus on behavioral aspects, BP involves complex interactions between behavioral, cognitive, and emotional components. This pilot study aimed to evaluate the effectiveness of Transdiagnostic Cognitive Behavioral Therapy in reducing bedtime procrastination by simultaneously targeting its behavioral, cognitive, and emotional dimensions. METHOD: In this double-blind randomized controlled trial, 32 university students with significant bedtime procrastination (BPS score ≥ 28) were randomly assigned to either a tCBT intervention (n = 16) or a wait-list control group (n = 16). The intervention consisted of 20 weekly one-hour sessions following the Unified Protocol. Outcomes were measured using the Bedtime Procrastination Scale (BPS), Sleep Beliefs Scale (SBS), and Difficulties in Emotion Regulation Scale (DERS) at pre-treatment, post-treatment, and 3-month follow-up. RESULTS: Mixed-model ANOVAs revealed significant time × group interactions for all outcome measures (p <.001). The intervention group showed substantial improvements in bedtime procrastination (η² = 0.404), emotion regulation (η² = 0.471), and sleep-related beliefs (η² = 0.404), with large effect sizes maintained at 3-month follow-up (Hedges' g = 1.29, 1.22, and 1.24 respectively). The wait-list group showed no significant changes. CONCLUSIONS: This study provides the first evidence for tCBT's effectiveness in treating bedtime procrastination through a comprehensive approach addressing multiple maintaining factors. The large effect sizes and maintenance of gains at follow-up suggest that targeting cognitive, behavioral, and emotional dimensions simultaneously may be more effective than single-component interventions. TRIAL REGISTRATION: This randomized clinical trial was registered in the Iranian Registry of Clinical Trials (IRCT Id: IRCT20200112046097N1). (Registration Date: 26/07/2020).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。